| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_804d38f8f31fb0afe893b96df63c0df5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 |
| filingDate |
2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f9c84ca1cbb0b02a4731c515b6423f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_823c91ae3548749dea1e057720243606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acae6dee983f68d83c1b440ead0fcc0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f7fa85fbc5821915bf9ec2a6f6e6d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3517686d44b0ee7fc0ee23e344e5ff2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f33c07dd075e858e69645e8def7f07e |
| publicationDate |
2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2592627-C |
| titleOfInvention |
Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
| abstract |
The present invention relates to a composition comprising at least one fibronectin binding protein, and/or at least one a truncated fibronectin binding protein and/or at least one fibronectin binding peptide, all comprising at least one fibronectin binding domain; and at least one Iscom matrixcomplex and/or liposome and/or at least one lipid and at least one saponin, whereby the at least one lipid and the at least one saponin may be in complex, solution or suspension. Further, it regards use thereof for the production of a vaccine against a micro organism that comprises at least one one fibronectin binding domain. It also regards a kit of parts comprising at least two compartments, wherein one compartment comprises at least one truncated fibronectin binding protein and/or a fibronectin binding peptide, that comprises at least one fibronectin binding domain, and another compartment comprises an instruction for use and/or an Iscom matrixcomplex and/or an iscom complex and or a liposome. Further it relates to a method for vaccination of an individual. |
| priorityDate |
2005-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |